Securities Code: 300253 Securities Abbreviation: Wining Health Announcement No.: 2026-071 Wining Health Technology Group Co., Ltd. Notice of Convening the Fourth Extraordinary General Meeting of Shareholders in 2026 The Company and all members of the Board of Directors guarantee the truthfulness, accuracy, and completeness of the information disclosed, and that there are no false records, misleading statements, or material omissions. I. Basic Information of the Meeting
- Session of the Shareholders' Meeting: The Fourth Extraordinary General Meeting of Shareholders in 2026
- Convener of the Shareholders' Meeting: The Board of Directors
- The convening and holding of this meeting comply with the relevant provisions of the Company Law of the People's Republic of China, the Listing Rules of the Shenzhen Stock Exchange ChiNext Market, the Shenzhen Stock Exchange Listed Company Self-Regulatory Supervision Guidelines No. 2 - Standardized Operation of ChiNext Listed Companies, and other laws, administrative regulations, departmental rules, normative documents, and the Articles of Association.
- Meeting Time: (1) On-site Meeting Time: 2:30 PM on July 8, 2026 (2) Online Voting Time: Online voting through the Shenzhen Stock Exchange system will be conducted from 9:15-9:25 AM, 9:30-11:30 AM, and 1:00-3:00 PM on July 8, 2026; voting through the Shenzhen Stock Exchange Internet Voting System will be conducted at any time between 9:15 AM and 3:00 PM on July 8, 2026.
- Method of Holding the Meeting: A combination of on-site voting and online voting.
- Equity Registration Date: July 1, 2026
- Attendees: (1) Ordinary shareholders (including preferred shareholders whose voting rights are restored) holding company shares on the equity registration date, or their authorized representatives. All ordinary shareholders (including preferred shareholders whose voting rights are restored) registered with the Shenzhen Branch of China Securities Depository and Clearing Corporation Limited as of the close of business on July 1, 2026, are entitled to attend the shareholders' meeting and vote in writing by entrusting an authorized representative. Such authorized representative need not be a shareholder of the Company (Appendix 2). Shareholders involved in the proposals of the shareholders' meeting shall abstain from voting. (2) All directors and senior management personnel of the Company. (3) The attesting lawyers and relevant personnel hired by the Company.
- Meeting Location: Meeting Room 16, Wining Health Building, Lane 99, Shouyang Road, Jing'an District, Shanghai. II. Matters to be Discussed at the Meeting
- Proposal Code Table for this Shareholders' Meeting | Proposal Code | Proposal Name | Proposal Type | Remarks | |---|---|---|---| | 100 | General Proposal: All proposals other than cumulative voting proposals | Non-cumulative Voting Proposal | √ | | 1.00 | "Proposal on the Board of Directors' Proposal to Lower the Conversion Price of 'Wining Convertible Bonds'" | Non-cumulative Voting Proposal | √ |
- The above proposals have been reviewed and approved by the 31st meeting of the Sixth Board of Directors of the Company held on June 22, 2026. For details, please refer to the announcement disclosed by the Company on the Juchao Information Network on